BioSpace News Archive

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, Nov. 2, 2023, at 8:00 a.m. ET to report its third quarter 2023 financial results and other business highlights.

NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”) today announced an upcoming poster presentation on a final report of a Phase I dose escalation study of SNK01 in subjects with Alzheimer’s Disease, at the 16th Clinical Trials on Alzheimer’s Disease Annual Meeting to be held in Boston, MA, USA from October 24–27, 2023.